MET and gallbladder cancer: Furthermore, genetic variations associated with inflammation, apoptosis, DNA repair, drug metabolism, hedgehog signaling, Wnt signaling, TGF-β, MET-related pathways, or aberrant levels of associated proteins have demonstrated significant associations with gallbladder cancer [7–9].